Zobrazeno 1 - 6
of 6
pro vyhledávání: '"B. R. Sreekanth"'
Publikováno v:
Acta Crystallographica Section E, Vol 64, Iss 5, Pp o800-o800 (2008)
The title compound, C12H17FNO+·Cl−, is a degradation impurity of paroxetine hydrochloride hemihydrate (PAXIL), an antidepressant belonging to the group of drugs called selective serotonin reuptake inhibitors (SSRIs). Similar to the paroxetine hydr
Externí odkaz:
https://doaj.org/article/11a64ee23eb240dda081f79f95085eae
Autor:
Rakeshwar Bandichhor, B. R. Sreekanth, Kushal Surajmal Manudhane, Srinivasula Reddy Maddula, Apurba Bhattacharya, Sridhar Thota
Publikováno v:
Organic Process Research & Development. 17:599-602
Novel and robust crystallization approach based on solid solution formation was developed for the purification of finasteride. This is an unprecedented approach that describes the use of pure finasteride 1 to purify different lots of finasteride 1 (i
Autor:
B. R. Sreekanth, Apurba Bhattacharya, Srinivasula Reddy Maddula, Kushal Surajmal Manudhane, Rakeshwar Bandichhor, Sridhar Thota
Publikováno v:
Organic Process Research & Development. 20:1689-1689
Novel and robust crystallization approach based on solid solution formation was developed for the purification of finasteride. This is an unprecedented approach that describes the use of pure finasteride 1 to purify different lots of finasteride 1 (i
Publikováno v:
Acta Crystallographica Section E: Structure Reports
The title compound, C(12)H(17)FNO(+)·Cl(-), is a degradation impurity of paroxetine hydro-chloride hemihydrate (PAXIL), an anti-depressant belonging to the group of drugs called selective serotonin reuptake inhibitors (SSRIs). Similar to the paroxet
Publikováno v:
CrystEngComm; Feb2008, Vol. 10 Issue 3, p283-287, 5p
Publikováno v:
Chemical Communications; Jun2007, Vol. 2007 Issue 23, p2375-2377, 3p